Insulin-Semilong Suspension

Insulin-Semilong suspension: a long-acting agent

Insulin-Semilong suspension belongs to the group of intermediate-acting insulins and is an important drug for people suffering from diabetes. This medication helps control blood glucose levels and helps maintain normal metabolic function.

The international name of this drug is Insulin-SrD. It is also known under various synonyms, including B-Insulin Berlin-Chemie, Berlinsulin N Basal U-40, Berlinsulin N Basal pen, Biogulin NPH U-100, Biogulin NPH U-40, Biogulin Lente U-40, Brinsulmidi MK, Brinsulmidi Ch , Brinsulmidi ChSP, V-Insulin SC Berlin-Chemie, Depo-Insulin S, Isofan Insulin, Isofan Insulin and others.

Insulin-Semilong suspension is available in the form of injections, which patients administer subcutaneously. It contains insulin, which is gradually released into the body, providing long-lasting action. This is especially useful for patients who require stable insulin levels over a long period of time.

The main mechanism of action of Insulin-Semilong suspension is its ability to reduce blood glucose levels. When insulin is given subcutaneously, it helps the body's cells use glucose as an energy source. This helps lower blood glucose levels and prevents them from rising to dangerous levels.

Insulin-Semilong suspension is usually prescribed to patients with type 1 and type 2 diabetes mellitus who require basal insulin therapy. It may be used in combination with other types of insulin or oral medications to achieve optimal glycemic control.

Like any other medical drug, Insulin-Semilong suspension has its own indications and contraindications. Patients should obtain recommendations and prescriptions from a physician to determine the correct dosage and route of administration.

It is important to note that self-medicating with insulin can be dangerous. Incorrect dosing or improper use of insulin can lead to serious complications, including hypoglycemia (low blood glucose levels) or hyperglycemia (increased blood glucose levels). Patients should follow the doctor's recommendations, regularly monitor their blood glucose levels and promptly report any changes or problems associated with the use of Insulin-Semilong suspension.

In conclusion, Insulin-Semilong suspension is a medium-acting pharmacological agent intended to control blood glucose levels in patients with diabetes mellitus. Its use should be under the supervision of a physician and in accordance with the dosage and use recommendations. Compliance with the correct use of Insulin-Semilong suspension will help patients achieve and maintain stable glycemic levels, which is an important factor for managing diabetes and maintaining overall health.